ASSESSMENT OF PHARMACISTS PROVIDING CARE IN THE OUT-PATIENT CLINICS SETTING THROUGH TELEMEDICINE MODELS IN MAKKAH CITY, SAUDI ARABIA IN 2022
Main Article Content
Keywords
assessment, pharmacists, providing, care, out-patient, clinics, telemedicine models, Makkah City.
Abstract
Background: Over the past 20 years, owing to rapid advances in technological innovation, namely in telecommunication and telemedicine, healthcare institutions have integrated clinical practices with cutting-edge telecommunication technology to enhance access to patient care, improve continuity of clinical care, and ensure patient safety. Pharmacists providing care in the out-patient clinics setting through telemedicine models. Pharmacy services were found to be essential in establishing outcome-oriented pharmacist-led medication management for patients. The established telemediation management clinic (MMC) services enhanced patient engagement and treatment compliance, and the integration process and its challenges were assessed. the pharmacist-led MMC services were beneficial to chronic disease patients and ensured the continuity of care, maintenance of up-to-date lab tests, management of polypharmacy, minimization of the use of unwanted medications and medication synchronization. Aim of the study: To Assessment of pharmacists providing care in the out-patient clinics setting through telemedicine models in Makkah City, Saudi Arabia in 2022. Method: cross sectional study conducted at outpatient clinics in Al-Aklas primary health care center in Makkah Al-Mukarramah Saudi Arabia in Sample population consists of Saudi out patients aged 20 to over than 60 years attending. Our total participants were (200). Results: Regarding the age majority of the study groups were in the age range of (20 - 40%) years were (37.0%) followed by (40-60) years were(33.0%), regarding the gender many of the respondents were male (58.0 %) while female were (42.0%). Regarding the education status, the majority of the respondents had Primary were (32.0%) , while Occupation the most of the participants answer Yes were (75.0%). Regarding the income The majority of them had an income from less than 3000SR were (31.0% ) .Conclusion: pharmacists providing care in the out-patient clinics setting through telemedicine models , based on pharmacist-led medication management services. The implementation of this model demonstrated a significant improvement in the clinical outcomes of patients and might help to improve the overall satisfaction during and after the peak pandemic period. The integration of the telehealth framework with a pharmacist-led medication management clinic was associated with promising outcomes in the access to and continuity of patient care during health care disruptions and the maintenance of pandemic regulations.
Downloads
References
1. Mohiuddin, S. I., Thorakkattil, S. A., Abushoumi, F., Nemr, H. S., Jabbour, R., & Al-Ghamdi, F. (2021). Implementation of pharmacist-led tele medication management clinic in ambulatory care settings: A patient-centered care model in COVID-19 Era. Exploratory Research in Clinical and Social Pharmacy, 4, 100083. 2. Bali, S. (2018). Enhancing the reach of health care through telemedicine: Status and new possibilities in developing countries. In Health care delivery and clinical science: Concepts, methodologies, tools, and applications (pp. 1382-1397). IGI Global. 3. Rout, S. K., Gabhale, Y. R., Dutta, A., Balakrishnan, S., Lala, M. M., Setia, M. S., ... & Manglani, M. V. (2019). Can telemedicine initiative be an effective intervention strategy for improving treatment compliance for pediatric HIV patients: Evidences on costs and improvement in treatment compliance from Maharashtra, India. PLoS One, 14(10), e0223303. 4. Margusino-Framiñán, L., Cid-Silva, P., Castro-Iglesias, Á., Mena-de-Cea, Á., Rodríguez-Osorio, I., Pernas-Souto, B., ... & Martín-Herranz, I. (2019). Teleconsultation for the pharmaceutical care of HIV outpatients in receipt of home antiretrovirals delivery: Clinical, economic, and patient-perceived quality analysis. Telemedicine and e-Health, 25(5), 399-406. 5. AlQarni, K., AlQarni, E. A., Naqvi, A. A., AlShayban, D. M., Ghori, S. A., Haseeb, A., ... & Jamshed, S. (2019). Assessment of medication adherence in Saudi patients with Type II diabetes mellitus in Khobar City, Saudi Arabia. Frontiers in pharmacology, 10, 1306. 6. Chitungo, I., Mhango, M., Mbunge, E., Dzobo, M., Musuka, G., & Dzinamarira, T. (2021). Utility of telemedicine in sub‐Saharan Africa during the COVID‐19 pandemic. A rapid review. Human behavior and emerging technologies, 3(5), 843-853. 7. Firnhaber, K., Banoo, S., Mokobori, M., & Strydom, B. (2018). Creating the pharmacies of the future–innovation through the appropriate use of technology. Africa Journal of Public Sector Development and Governance, 1(1), 71-81. 8. Itani, R., Khojah, H. M., Jaffal, F., Rahme, D., Karout, L., & Karout, S. (2021). Provision of pharmaceutical care to suspected high-risk COVID-19 patients through telehealth: a nationwide simulated patient study. BMC health services research, 21(1), 1-10. 9. Verhoeven, V., Tsakitzidis, G., Philips, H., & Van Royen, P. (2020). Impact of the COVID-19 pandemic on the core functions of primary care: will the cure be worse than the disease? A qualitative interview study in Flemish GPs. BMJ open, 10(6), e039674. 10. Dhingra, D., & Dabas, A. (2020). Global strategy on digital health. Indian pediatrics, 57(4), 356-358. 11. Senbekov, M., Saliev, T., Bukeyeva, Z., Almabayeva, A., Zhanaliyeva, M., Aitenova, N., ... & Fakhradiyev, I. (2020). The recent progress and applications of digital technologies in healthcare: a review. International journal of telemedicine and applications, 2020. 12. D’Amario, D., Canonico, F., Rodolico, D., Borovac, J. A., Vergallo, R., Montone, R. A., ... & Crea, F. (2020). Telemedicine, artificial intelligence and humanisation of clinical pathways in heart failure management: back to the future and beyond. Cardiac Failure Review, 6. 13. Phillips, A. (2021). Artificial intelligence-enabled healthcare delivery and digital epidemiological surveillance in the remote treatment of patients during the COVID-19 pandemic. American Journal of Medical Research, 8(1), 40-49. 14. Zarowitz, B. J. (2020). Emerging Pharmacotherapy and Health Care Needs of Patients in the Age of Artificial Intelligence and Digitalization. Annals of Pharmacotherapy, 54(10), 1038-1046. 15. Kane-Gill, S. L., Niznik, J. D., Kellum, J. A., Culley, C. M., Boyce, R. D., Marcum, Z. A., ... & Handler, S. M. (2017). Use of telemedicine to enhance pharmacist services in the nursing facility. The Consultant Pharmacist®, 32(2), 93-98. 16. Mohiuddin, S. I., Thorakkattil, S. A., Abushoumi, F., Nemr, H. S., Jabbour, R., & Al-Ghamdi, F. (2021). Implementation of pharmacist-led tele medication management clinic in ambulatory care settings: A patient-centered care model in COVID-19 Era. Exploratory Research in Clinical and Social Pharmacy, 4, 100083. 17. Yezli, S., & Khan, A. (2020). COVID-19 social distancing in the Kingdom of Saudi Arabia: Bold measures in the face of political, economic, social and religious challenges. Travel medicine and infectious disease, 37, 101692. 18. Alanzi, T. (2021). A review of mobile applications available in the app and google play stores used during the COVID-19 outbreak. Journal of multidisciplinary healthcare, 14, 45. 19. Alsahali, S. (2021). Awareness, Views, Perceptions, and Beliefs of Pharmacy Interns Regarding Digital Health in Saudi Arabia: Cross-sectional Study. JMIR Medical Education, 7(3), e31149. 20. Haleem, A., Javaid, M., Singh, R. P., & Suman, R. (2021). Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sensors International, 2, 100117. 21. Kinninmont, J. (2017). Vision 2030 and Saudi Arabia’s social contract. Austerity and transformation’, Chattham House, London. 22. Hazazi, A., & Wilson, A. (2021). Leveraging electronic health records to improve management of noncommunicable diseases at primary healthcare centres in Saudi Arabia: a qualitative study. BMC Family Practice, 22(1), 1-6. 23. Ahmed, Y. A., Alrashidi, I. M., Aljowyyan, M. H., Alasmari, A. M., AlHarbi, K. F., Saleh, S. S., ... & Faqihi, A. M. The impact of COVID-19 on Digital health and care in Saudi Arabia. 24. Binkheder, S., Aldekhyyel, R. N., AlMogbel, A., Al-Twairesh, N., Alhumaid, N., Aldekhyyel, S. N., & Jamal, A. A. (2021). Public Perceptions around mHealth Applications during COVID-19 Pandemic: A Network and Sentiment Analysis of Tweets in Saudi Arabia. International Journal of Environmental Research and Public Health, 18(24), 13388. 25. Bano, M., Zowghi, D., & Arora, C. (2020). Requirements, politics, or individualism: What drives the success of covid-19 contact-tracing apps?. Ieee Software, 38(1), 7-12. 26. Abu-Farha, R., Mukattash, T., Itani, R., Karout, S., Khojah, H. M., Al-Mahmood, A. A., & Alzoubi, K. H. (2021). Willingness of Middle Eastern public to receive COVID-19 vaccines. Saudi pharmaceutical journal, 29(7), 734-739. 27. Kong, S. S., Azarfar, A., Ashour, A., Atkins, C., & Bhanusali, N. (2020). Awareness and attitudes towards telemedicine among medical students in the United States. Cureus, 12(11). 28. Bhutta, Z. A., Basnyat, B., Saha, S., & Laxminarayan, R. (2020). Covid-19 risks and response in South Asia. Bmj, 368. 29. Volerman, A., Kan, K., Carpenter, D., & Press, V. G. (2021). Strategies for improving inhalation technique in children: A narrative review. Patient preference and adherence, 15, 665. 30. Whaibeh, E., Mahmoud, H., & Naal, H. (2020). Telemental health in the context of a pandemic: the COVID-19 experience. Current Treatment Options in Psychiatry, 7(2), 198-202.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.